We are live on ! Find out more
CIC

Carnegie Investment Counsel Portfolio holdings

AUM $4.99B
1-Year Est. Return 23.08%
This Fund
S&P 500
This Quarter Est. Return
-11.72%
1 Year Est. Return
+23.08%
3 Year Est. Return
+101.05%
5 Year Est. Return
+118.22%
10 Year Est. Return
+474.28%
AUM
$1.08B
AUM Growth
-$142M
Cap. Flow
-$29.1M
Cap. Flow %
-2.71%
Top 10 Hldgs %
19.16%
Holding
407
New
74
Increased
91
Reduced
198
Closed
41

Top Sells

Rank Stock Value
1
NOC icon
Northrop Grumman
NOC
+$15.1M
2
DD icon
DuPont de Nemours
DD
+$7.88M
3
NEOG icon
Neogen
NEOG
+$7.8M
4
MSFT icon
Microsoft
MSFT
+$6.75M
5
ZTS icon
Zoetis
ZTS
+$5.38M

Sector Composition

Rank Sector Weight
1 Financials 15.63%
2 Industrials 11.87%
3 Technology 10.72%
4 Healthcare 10.04%
5 Consumer Discretionary 6.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBDO
326
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
$243K 0.02%
+10,047
New +$242K
EMN icon
327
Eastman Chemical
EMN
$8.44B
$241K 0.02%
+3,300
New +$263K
IVE icon
328
iShares S&P 500 Value ETF
IVE
$49.9B
$241K 0.02%
2,378
+550
+30% +$60.2K
TXN icon
329
Texas Instruments
TXN
$261B
$239K 0.02%
2,527
-227
-8% -$22K
TTE icon
330
TotalEnergies
TTE
$194B
$234K 0.02%
+410,297
New +$257K
EL icon
331
Estee Lauder
EL
$31.7B
$231K 0.02%
+1,775
New +$241K
IBDK
332
DELISTED
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
$230K 0.02%
+9,260
New +$229K
F icon
333
Ford
F
$55.6B
$228K 0.02%
29,790
-15,491
-34% -$138K
IXJ icon
334
iShares Global Healthcare ETF
IXJ
$4.21B
$227K 0.02%
4,000
-1,000
-20% -$59.8K
PBE icon
335
Invesco Biotechnology & Genome ETF
PBE
$357M
$227K 0.02%
4,815
-515
-10% -$26.5K
TRV icon
336
Travelers Companies
TRV
$78.7B
$227K 0.02%
1,893
-557
-23% -$69.7K
SJM icon
337
J.M. Smucker
SJM
$12.6B
$224K 0.02%
2,395
-823
-26% -$85.9K
FITB
338
Fifth Third Bancorp
FITB
$52.1B
$219K 0.02%
9,309
-300
-3% -$7.89K
VOOG icon
339
Vanguard S&P 500 Growth ETF
VOOG
$27.2B
$217K 0.02%
9,630
-5,430
-36% -$131K
EQR icon
340
Equity Residential
EQR
$24.2B
$215K 0.02%
3,250
DOC icon
341
Healthpeak Properties
DOC
$14.3B
$213K 0.02%
7,625
-3,300
-30% -$91.3K
ITOT icon
342
iShares Core S&P Total US Stock Market ETF
ITOT
$97.8B
$213K 0.02%
3,758
IYT icon
343
iShares US Transportation ETF
IYT
$2.27B
$213K 0.02%
+5,168
New +$239K
MKL icon
344
Markel Group
MKL
$22.8B
$213K 0.02%
+205
New +$224K
EFX icon
345
Equifax
EFX
$21B
$212K 0.02%
+2,277
New +$242K
AMTD
346
DELISTED
TD Ameritrade Holding Corp
AMTD
$211K 0.02%
+4,300
New +$219K
STI
347
DELISTED
SunTrust Banks, Inc.
STI
$211K 0.02%
+4,185
New +$251K
ATO icon
348
Atmos Energy
ATO
$28.6B
$210K 0.02%
+2,260
New +$216K
CNI icon
349
Canadian National Railway
CNI
$76.6B
$210K 0.02%
+2,828
New +$234K
VFH icon
350
Vanguard Financials ETF
VFH
$13.8B
$210K 0.02%
+3,539
New +$230K

Similar funds

Carnegie Investment Counsel's Q4 2018 Portfolio in Review

As of Q4 2018, Carnegie Investment Counsel held 407 positions worth $1.08B, down 12% from $1.22B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Carnegie Investment Counsel's Q4 2018 filing shows 74 new, 91 increased, 198 reduced and 41 closed positions. Its largest new stake was Berkshire Hathaway Class B: 118,190 shares worth $24.1M. The largest sale was Northrop Grumman, an estimated $15.1M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 13% a quarter earlier, followed by Industrials and Technology.

  • Carnegie Investment Counsel's largest Q4 2018 buy was Berkshire Hathaway Class B: 118,190 shares worth $24.1M.
  • Carnegie Investment Counsel added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $10.4M increase.
  • Carnegie Investment Counsel's biggest Q4 2018 reduction was Northrop Grumman, cutting an estimated $15.1M.
  • Carnegie Investment Counsel fully exited D.R. Horton in Q4 2018, selling an estimated $2.14M.
  • Carnegie Investment Counsel's ten largest holdings make up 19% of its $1.08B portfolio in Q4 2018.
  • Carnegie Investment Counsel opened 74 new positions and closed 41 in Q4 2018.
  • Carnegie Investment Counsel's portfolio value fell 12% quarter-over-quarter to $1.08B.

Based on Carnegie Investment Counsel's 13F filing for Q4 2018, filed 14 Feb 2019.